Ocimum Biosolutions, a life sciences RD enabling company, has set up its German subsidiary in Ebersberg (Germany) in a bid to expand its presence in the European market.

This is a key milestone for Ocimum after its successful acquisition of the Microarrays division of MWG Biotech AG. The German subsidiary, Ocimum Germany GmbH, aims to tap the huge genomics market in Europe and provide quality R&D enabling solutions to universities, research institutes, biotech and pharma companies in Europe.

In a statement, Anuradha Acharya, CEO, Ocimum, said, "Eupore is a big market for us. We chose to base our European operations in Germany as it is centrally located in Europe."

"This is one more consequent step in Ocimum´s overall strategy and a clear commitment to our customers", Ludwig Winzer, managing director of the Ocimum Germany GmbH added.

Ocimum is planning to expand further in the market through acquisitions.